FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Haloperidol Decanoate Injection
Status: Discontinuation
»Therapeutic Categories: Psychiatry

Expand all

Fresenius Kabi USA, LLC (New 01/09/2026)

Company Contact Information:
888-386-1300

Presentation	Posting Date	Related Information
Haloperidol Decanoate, Injection, 50 mg/1 mL (NDC 63323-469-01)	01/09/2026	Discontinuation of the manufacture of the drug
Haloperidol Decanoate, Injection, 50 mg/1 mL (NDC 63323-469-05)	01/09/2026	Discontinuation of the manufacture of the drug

Janssen Pharmaceuticals (New 04/07/2025)

Company Contact Information:
800-526-7736

Presentation	Posting Date	Related Information
Haloperidol Decanoate, Injection, 50 mg/1 mL (NDC 10147-0921-3)	04/07/2025	Marketed by Patriot Pharmaceuticals LLC; Last batch expiration date 5/31/2025
Haloperidol Decanoate, Injection, 100 mg/1 mL (NDC 10147-0922-5)	04/07/2025	Marketed by Patriot Pharmaceuticals LLC; Last batch expiration date 10/31/2025
Haldol, Injection, 50 mg/1 mL (NDC 50458-253-03)	04/07/2025	Last batch expiration date 5/31/2025
Haldol, Injection, 100 mg/1 mL (NDC 50458-254-14)	04/07/2025	Last batch expiration date 8/31/2025